Suppr超能文献

一种新型 GPIHBP1 突变导致家族性乳糜微粒血症综合征。

A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome.

机构信息

Nutrition, Metabolism and Atherosclerosis Clinic, Institut de recherches cliniques de Montréal, Québec, Canada.

Department of Medicine, University of Western Ontario and Robarts Research Institute, Ontario, Canada.

出版信息

J Clin Lipidol. 2018 Mar-Apr;12(2):506-510. doi: 10.1016/j.jacl.2018.01.011. Epub 2018 Jan 31.

Abstract

Familial chylomicronemia syndrome is characterized by severe elevation in serum triglycerides and an increased risk of acute pancreatitis. Although familial chylomicronemia syndrome is mainly caused by mutations in the lipoprotein lipase (LPL) gene, few causal mutations in other genes (ie, APOC2, APOA5, LMF1, and GPIHBP1) have also been reported. In this case report, we present the discovery of a novel mutation in the glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1) gene and discuss its pathogenicity through a familial segregation study.

摘要

家族性乳糜微粒血症综合征的特征是血清甘油三酯水平严重升高,急性胰腺炎风险增加。虽然家族性乳糜微粒血症综合征主要由脂蛋白脂肪酶(LPL)基因突变引起,但也有少数其他基因(即 APOC2、APOA5、LMF1 和 GPIHBP1)的致病突变报道。在本病例报告中,我们发现了一个糖基磷脂酰肌醇锚定高密度脂蛋白结合蛋白 1(GPIHBP1)基因的新突变,并通过家族分离研究探讨了其致病性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验